AU Stock MarketDetailed Quotes
CUV Clinuvel Pharmaceuticals Ltd
- 13.150
- +0.060+0.46%
20min DelayMarket Closed Nov 29 16:00 AET
658.30MMarket Cap18.84P/E (Static)
13.200High12.970Low61.47KVolume13.100Open13.090Pre Close804.47KTurnover18.14052wk High0.15%Turnover Ratio50.06MShares12.80052wk Low0.698EPS TTM544.01MFloat Cap45.422Historical High18.84P/E (Static)41.37MShs Float0.173Historical Low0.698EPS LYR1.76%Amplitude0.05Dividend TTM3.24P/B1Lot Size0.38%Div YieldTTM
Clinuvel Pharmaceuticals Ltd Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | (FY)Jun 30, 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||||
| Cash income from operating activities | 12.92%84.57M | 12.43%74.9M | 71.59%66.62M | 32.01%38.82M | -8.73%29.41M | 35.62%32.22M | 28.34%23.76M | 407.41%18.51M | 43.35%3.65M | 34.32%2.55M |
| Revenue from customers | 12.21%84.02M | 12.77%74.88M | 71.47%66.4M | 32.22%38.72M | -9.10%29.29M | 35.92%32.22M | 32.25%23.71M | 391.29%17.92M | 43.35%3.65M | 34.32%2.55M |
| Income from government grants | 1,464.79%344.39K | -89.87%22.01K | --217.26K | ---- | ---- | ---- | --53.07K | ---- | ---- | ---- |
| Other cash income from operating activities | --208.59K | ---- | ---- | -18.25%99.36K | --121.54K | ---- | ---- | --588.02K | ---- | ---- |
| Cash paid | -19.62%-39.75M | -21.49%-33.23M | -36.54%-27.35M | -23.04%-20.03M | -14.32%-16.28M | -13.57%-14.24M | -38.99%-12.54M | 3.89%-9.02M | -17.19%-9.39M | 0.63%-8.01M |
| Payments to suppliers for goods and services | -19.62%-39.75M | -21.49%-33.23M | -36.54%-27.35M | -23.04%-20.03M | -14.32%-16.28M | -13.57%-14.24M | -38.99%-12.54M | 3.89%-9.02M | -17.19%-9.39M | 0.63%-8.01M |
| Direct interest received | 179.89%7.63M | 995.24%2.73M | -36.31%249K | -38.59%390.97K | 44.39%636.63K | 51.74%440.92K | 24.34%290.57K | 39.46%233.68K | -52.66%167.56K | 5.88%353.96K |
| Direct tax refund paid | -105.83%-15.4M | -2,186.50%-7.48M | 350.14%358.69K | -81.18%79.68K | 1,100.16%423.37K | -80.81%35.28K | -4.75%183.84K | -63.88%193.01K | -8.06%534.3K | -43.19%581.11K |
| Operating cash flow | 0.38%37.05M | -7.42%36.91M | 107.00%39.87M | 35.76%19.26M | -23.12%14.19M | 57.83%18.46M | 17.91%11.69M | 296.88%9.92M | -11.20%-5.04M | 5.80%-4.53M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -2,725.60%-29.03M | -136.52%-1.03M | 49.15%-434.44K | 3.88%-854.33K | -245.02%-888.83K | -242.93%-257.62K | -11.33%-75.12K | 31.18%-67.48K | -816.62%-98.05K | -211.32%-10.7K |
| Net PPE purchase and sale | -442.68%-5.58M | -136.52%-1.03M | 49.15%-434.44K | 3.88%-854.33K | -245.02%-888.83K | -242.93%-257.62K | -11.33%-75.12K | 31.18%-67.48K | -816.62%-98.05K | -211.32%-10.7K |
| Net investment purchase and sale | ---23.46M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -2,725.60%-29.03M | -136.52%-1.03M | 49.15%-434.44K | 3.88%-854.33K | -245.02%-888.83K | -242.93%-257.62K | -11.33%-75.12K | 31.18%-67.48K | -816.62%-98.05K | -211.32%-10.7K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -59.45%-3.57M | -48.97%-2.24M | -1.61%-1.5M | 0.40%-1.48M | -44.17%-1.49M | -1.03M | -98.99%85.08K | 3,666.67%8.39M | -96.76%222.7K | |
| Net issuance payments of debt | ---- | ---- | ---- | ---- | 74.83%-18.5K | ---73.51K | ---- | ---- | ---- | ---- |
| Net common stock issuance | ---754.24K | ---- | ---- | ---- | ---- | ---- | ---- | -98.97%85.08K | 3,626.65%8.3M | -96.76%222.7K |
| Cash dividends paid | -24.99%-2.47M | -60.00%-1.98M | 0.00%-1.24M | -0.92%-1.24M | -27.88%-1.22M | ---957.16K | ---- | ---- | ---- | ---- |
| Interest paid (cash flow from financing activities) | ---- | ---- | ---- | ---44.41K | ---- | ---- | ---- | ---- | ---- | ---- |
| Net other financing activities | -31.71%-347.34K | 1.78%-263.72K | -34.06%-268.49K | 17.70%-200.28K | ---243.34K | ---- | ---- | ---- | --89.12K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -59.45%-3.57M | -48.97%-2.24M | -1.61%-1.5M | 0.40%-1.48M | -44.17%-1.49M | ---1.03M | ---- | -98.99%85.08K | 3,666.67%8.39M | -96.76%222.7K |
| Net cash flow | ||||||||||
| Beginning cash position | -73.75%31.89M | 46.94%121.51M | 23.89%82.69M | 22.99%66.75M | 49.92%54.27M | 52.40%36.2M | 71.56%23.75M | 30.95%13.84M | -27.71%10.57M | 16.36%14.63M |
| Current changes in cash | -86.78%4.45M | -11.31%33.64M | 124.09%37.93M | 43.29%16.93M | -31.19%11.81M | 47.77%17.17M | 16.95%11.62M | 205.36%9.93M | 175.35%3.25M | -308.62%-4.32M |
| Effect of exchange rate changes | -168.71%-1.14M | 87.72%1.66M | 189.92%884.21K | -248.07%-983.32K | -26.42%664.08K | 9.00%902.48K | 3,174.37%827.93K | -241.53%-26.93K | -92.81%19.03K | 2,146.58%264.52K |
| End cash Position | -77.55%35.2M | 29.05%156.81M | 46.94%121.51M | 23.89%82.69M | 22.99%66.75M | 49.92%54.27M | 52.40%36.2M | 71.56%23.75M | 30.95%13.84M | -27.71%10.57M |
| Free cash from | -12.28%31.48M | -9.01%35.88M | 114.25%39.44M | 38.41%18.41M | -26.92%13.3M | 56.64%18.2M | 17.96%11.62M | 291.81%9.85M | -13.06%-5.13M | 5.62%-4.54M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data